These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6244733)

  • 21. Summary: symposium on Epstein-Barr virus-induced lymphoproliferative diseases in immunodeficient patients.
    Klein G; Purtilo D
    Cancer Res; 1981 Nov; 41(11 Pt 1):4302-4. PubMed ID: 6272974
    [No Abstract]   [Full Text] [Related]  

  • 22. Lymphocyte reactivity in infectious mononucleosis.
    ten Napel CH; The TH
    J Infect Dis; 1980 Jun; 141(6):716-23. PubMed ID: 6248602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention and treatment of Epstein-Barr virus (EBV)-associated lymphoproliferative diseases in immune deficient patients.
    Purtilo DT
    AIDS Res; 1986 Dec; 2 Suppl 1():S177-81. PubMed ID: 2435295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epstein-Barr virus antibodies in patients with ataxia-telangiectasia and other immunodeficiency diseases.
    Joncas JH; Wills A; Reece E; Fox Z
    Can Med Assoc J; 1981 Oct; 125(8):845-9. PubMed ID: 6272957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characteristic T cell dysfunction in patients with chronic active Epstein-Barr virus infection (chronic infectious mononucleosis).
    Tosato G; Straus S; Henle W; Pike SE; Blaese RM
    J Immunol; 1985 May; 134(5):3082-8. PubMed ID: 2984282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunodeficiency to the Epstein-Barr virus in the X-linked recessive lymphoproliferative syndrome.
    Purtilo DT; Hutt L; Bhawan J; Yang JP; Cassel C; Allegra S; Rosen FS
    Clin Immunol Immunopathol; 1978 Feb; 9(2):147-56. PubMed ID: 201410
    [No Abstract]   [Full Text] [Related]  

  • 27. Infectious mononucleosis with atypical manifestations accompanied by transient IgM antibody response for cytomegalovirus.
    Nishikawa J; Funada H; Miyazaki T; Fujinami H; Miyazono T; Murakami J; Kudo T; Sugiyama T
    J Infect Chemother; 2011 Oct; 17(5):686-8. PubMed ID: 21327688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immunologic indexes, enzyme status of lymphocytes and functional activity of blood neutrophils in children with infectious mononucleosis caused by Epstein-Barr virus].
    Kurtasova LM; Tolstikova AE; Savchenko AA
    Vestn Ross Akad Med Nauk; 2013; (7):42-6. PubMed ID: 24340961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epstein-Barr-virus-induced oncogenesis in immune-deficient individuals.
    Purtilo DT
    Lancet; 1980 Feb; 1(8163):300-3. PubMed ID: 6101750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fatal infectious mononucleosis with staphylococcal pyoderma in a girl with hereditary immunological dysregulations.
    Inaba T; Hanada R; Yaginuma A; Hayashi Y; Yamamoto K; Hukada H
    Eur J Pediatr; 1989 Dec; 149(3):177-8. PubMed ID: 2612506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [X-chromosomal recessively inherited lymphoproliferative syndrome. An analysis of EBV-induced immune deficiency].
    Kammermeier-Schmidt U; Weiss M; Belohradsky BH
    Monatsschr Kinderheilkd; 1993 Mar; 141(3):201-6. PubMed ID: 8386321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A prospective clinical study of Epstein-Barr virus and host interactions during acute infectious mononucleosis.
    Balfour HH; Holman CJ; Hokanson KM; Lelonek MM; Giesbrecht JE; White DR; Schmeling DO; Webb CH; Cavert W; Wang DH; Brundage RC
    J Infect Dis; 2005 Nov; 192(9):1505-12. PubMed ID: 16206064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of Epstein-Barr virus production in P3HR-1 cells by Epstein-Barr virus-seropositive human serum.
    Sairenji T; Bertoni G; Medveczky MM; Medveczky PG; Humphreys RE
    Intervirology; 1991; 32(1):37-51. PubMed ID: 1849877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by Epstein-Barr virus complementary RNA/DNA and viral DNA/DNA hybridization.
    Saemundsen AK; Purtilo DT; Sakamoto K; Sullivan JL; Synnerholm AC; Hanto D; Simmons R; Anvret M; Collins R; Klein G
    Cancer Res; 1981 Nov; 41(11 Pt 1):4237-42. PubMed ID: 6272968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinetics of Epstein-Barr Virus (EBV) Neutralizing and Virus-Specific Antibodies after Primary Infection with EBV.
    Bu W; Hayes GM; Liu H; Gemmell L; Schmeling DO; Radecki P; Aguilar F; Burbelo PD; Woo J; Balfour HH; Cohen JI
    Clin Vaccine Immunol; 2016 Apr; 23(4):363-9. PubMed ID: 26888186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of suppressor T cells during Epstein-Barr-virus-induced infectious mononucleosis.
    Tosato G; Magrath I; Koski I; Dooley N; Blaese M
    N Engl J Med; 1979 Nov; 301(21):1133-7. PubMed ID: 226884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Virological and immunological studies on inapparent Epstein-Barr virus infection in healthy individuals: in comparison to immunosuppressed patients and patients with infectious mononucleosis].
    Imai S
    Hokkaido Igaku Zasshi; 1990 Sep; 65(5):481-92. PubMed ID: 2172132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Epstein-Barr-virus-induced lymphoproliferative diseases].
    Schuster V; Kreth HW
    Monatsschr Kinderheilkd; 1991 Jul; 139(7):396-400. PubMed ID: 1656248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Infectious mononucleosis in an adult progressing to fatal immunoblastic lymphoma.
    Snydman DR; Rudders RA; Daoust P; Sullivan JL; Evans AS
    Ann Intern Med; 1982 Jun; 96(6 Pt 1):737-42. PubMed ID: 6283976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antineutrophil antibodies in infectious mononucleosis.
    Schooley RT; Densen P; Harmon D; Felsenstein D; Hirsch MS; Henle W; Weitzman S
    Am J Med; 1984 Jan; 76(1):85-90. PubMed ID: 6318560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.